Research Site

Frankfurt A. Main 60590

1 studies enrolling now · 3 studies all time

What they study most

Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Carcinoma, Higher-risk Myelodysplastic Syndromes, NSCLC, Non-Small-Cell Lung

Studies at this site

• Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression — Recruiting now
• Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment — Running, not enrolling
• Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations — Running, not enrolling